Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Indian Drug Makers Offer Deal To Avoid Increased Price Controls

This article was originally published in PharmAsia News

Executive Summary

Drug makers in India are offering to sell some of their more important products at half of their maximum retail price to stave off greater price controls. But their offer is conditioned on the Indian government promising not to expand its cost-based price control policy. In addition to the half-off offer on some drugs, companies are offering to contribute a quarter of a percent of total profits to the government. An acceptance by the government would be considered a big change in the way India deals with the increasing cost of health care. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068208

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel